• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAA 0.00% 17.5¢

PHARMAUST LIMITED

PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for... PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for human and animal health applications. The Company’s segments include Corporate and Research. The Company is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The Company's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The Company is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. It is focused on starting Phase II/III clinical study of MPL. It has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. It is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAA
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
2 3 4
14:44 211 40K
14:44 Last post  NickEegz Comments Created with Sketch.  211  Views Created with Sketch.  40K 
PAA
Price manipulation
21/05/24 35 7.6K
21/05/24 Last post  TheAnalyst007 Comments Created with Sketch.  35  Views Created with Sketch.  7.6K 
PAA 20/05/24 47 11K
TRENDING NEWS

Don't miss this unique opportunity! Unlock the secrets of ASX healthcare investments

NEWS
22 May 2024
20/05/24 Last post  FloatingCity Comments Created with Sketch.  47  Views Created with Sketch.  11K 
PAA 20/05/24 86 20K
20/05/24 Last post  NZ Trader Comments Created with Sketch.  86  Views Created with Sketch.  20K 
PAA 20/05/24 7 2.1K
20/05/24 Last post  NZ Trader Comments Created with Sketch.  7  Views Created with Sketch.  2.1K 
PAA
Shareholders Not Walking The Walk
19/05/24 0 256
19/05/24 Last post  Captain Goodvybes Comments Created with Sketch.  0  Views Created with Sketch.  256 
PAA
PAA TOP HOLDERS MOVEMENTS AS AT 30 APRIL 2024
19/05/24 7 2.6K
19/05/24 Last post  RAN58 Comments Created with Sketch.  7  Views Created with Sketch.  2.6K 
PAA 19/05/24 43 11K
19/05/24 Last post  Havenots Comments Created with Sketch.  43  Views Created with Sketch.  11K 

See All Discussions arrow Created with Sketch.

Timeline

Investor Webinar Presentation
17 May 18:30
 
PharmAust receives Orphan Drug Designation for monepantel
17 May 09:58
 
Initial Director's Interest Notice
17 May 09:13
 
Final Director's Interest Notice
17 May 09:09
 
PharmAust appoints Sergio Duchini as Non-Executive Chairman
17 May 09:08
 
Final Director's Interest Notice
14 May 08:23
 
View More arrow Created with Sketch.
(20min delay)
Last
17.5¢
Change
0.000(0.00%)
Mkt cap ! $71.26M
Open High Low Value Volume
17.5¢ 18.0¢ 17.5¢ $111.1K 622.5K

Buyers (Bids)

No. Vol. Price($)
9 91508 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 571848 11
View Market Depth
Last trade - 14.41pm 22/05/2024 (20 minute delay) ?
Last
18.0¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
18.0¢ 18.0¢ 17.5¢ 117244
Last updated 12.50pm 22/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.